Compare ARK Genomic Revolution ETF (ARKG) vs Vanguard Short Term Corporate Bond ETF (VCSH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Vanguard Short Term Corporate Bond ETF — how do they compare? ARK Genomic Revolution ETF trades at $44.44, while Vanguard Short Term Corporate Bond ETF trades at $78.68. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Vanguard Short Term Corporate Bond ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | VCSH | |
|---|---|---|
Sector | Sector/Thematic | Fixed Income |
52-Week High | $44.69 | $80.20 |
52-Week Low | $24.02 | $78.41 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Vanguard Short Term Corporate Bond ETF
VCSH tracks the Bloomberg U.S. 1-5 Year Corporate Bond Index, focusing on high-quality, investment-grade debt with short maturities. It is designed to offer higher income than Treasury bills with significantly lower interest rate sensitivity than intermediate or long-term bond funds.
Read more on VCSH →
